Highlights and Quick Summary
- Net Profit Margin for the quarter ending September 30, 2023 was -2956.18% (a 138.85% increase compared to previous quarter)
- Year-over-year quarterly Net Profit Margin increased by 136.39%
- Annual Net Profit Margin for 2022 was -1825.37% (a -15.45% decrease from previous year)
- Annual Net Profit Margin for 2021 was -2159.01% (a 108.62% increase from previous year)
- Annual Net Profit Margin for 2020 was -1034.92% (a -10.69% decrease from previous year)
- Twelve month Net Profit Margin ending September 30, 2023 was -1535.13% (a 17.61% increase compared to previous quarter)
- Twelve month trailing Net Profit Margin decreased by -15.9% year-over-year
Trailing Net Profit Margin for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| -1535.13% | -1305.27% | -1593.76% | -1825.37% |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Profit Margin of Absci Corporation
Most recent Net Profit Marginof ABSI including historical data for past 10 years.Interactive Chart of Net Profit Margin of Absci Corporation
Absci Corporation Net Profit Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -2956.18% | -1237.66% | -1840.43% | – | – |
| 2022 | -1250.55% | -1150.65% | -2862.28% | -3601.22% | -1825.37% |
| 2021 | -1733.2% | -1551.4% | -5802.88% | -1124.84% | -2159.01% |
| 2020 | -181.05% | -1415.17% | -3009.75% | -2414.69% | -1034.92% |
| 2019 | – | – | – | – | -1158.74% |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology